Comprehensive Assessment of Cardiac Function in Breast Cancer Patients: Integrating Multiparametric Speckle Tracking

Marina Leitman1,2, Shmuel Fuchs1,2, Oran Tzuman1,2

  • 1Cardiology, Shamir Medical Center, Zerifin, ISR.

Cureus
|May 9, 2024
PubMed

Insights

Global longitudinal strain (GLS) and ejection fraction (EF) are key echocardiography metrics affected by chemotherapy in breast cancer patients. Certain medications may offer cardioprotection against chemotherapy-induced cardiac damage.

Area of Science:

  • Cardiology
  • Oncology
  • Medical Imaging

Background:

  • Echocardiography, particularly ejection fraction (EF), is crucial for monitoring breast cancer patients during chemotherapy.
  • Limitations of EF include operator dependence and insensitivity to subtle changes in left ventricular (LV) contractility.
  • Global longitudinal strain (GLS) via speckle tracking offers greater sensitivity and stability than EF.

Purpose of the Study:

  • To evaluate various echocardiography parameters for monitoring breast cancer patients undergoing chemotherapy.
  • To identify supplementary echocardiography measurements for improved cardiological surveillance.
  • To assess the impact of chemotherapy on cardiac mechanics and contractility.

Main Methods:

  • Longitudinal echocardiography follow-up (baseline, during, post-chemotherapy) in 25 breast cancer patients.
  • Assessment of conventional echocardiography and speckle tracking imaging parameters (GLS, myocardial work index, atrial strain, twist, EF).
  • Comparison of manual and automated EF measurement methods.

Main Results:

  • Fifteen patients showed significant GLS reduction, correlating with decreased EF and altered cardiac mechanics.
  • Patients with stable GLS often had hypertension and were on ACE inhibitors/ARBs, suggesting cardioprotective effects.
  • GLS and EF demonstrated higher sensitivity to chemotherapy effects compared to other parameters.
  • A strong correlation was found between manual and automated EF measurements.

Conclusions:

  • GLS and EF are the primary echocardiography parameters impacted by chemotherapy in breast cancer patients.
  • Hypertension and treatment with ACE inhibitors/ARBs may mitigate chemotherapy-induced cardiac damage.
  • Automated EF measurements correlate strongly with traditional methods, supporting their clinical utility.